ArticleJAMA cardiology2021

Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.

Justin T Parizo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.